Panbela Therapeutics Inc (NASDAQ:PBLA)
| 1.46 Delayed Data As of May 24 |  0.00 / 0.00%Today’s Change | 1.45 Today|||52-Week Range 4.78 | -15.61% Year-to-Date |
Latest PBLA News | Press Releases
No recent news for Panbela Therapeutics Inc.
Today’s Trading
| Previous close | 1.46 |
| Today’s open | 1.53 |
| Day’s range | 1.46 - 1.53 |
| Volume | 200 |
| Average volume (3 months) | 32,143 |
| Market cap | $32.3M |
Data as of 2:57pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | -40.38% |
| Earnings growth (this year) | -8.43% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INDPIndaptus Therapeutic... | +0.02 | +0.85% |
| ---- | ||
| QLGNQualigen Therapeutic... | -0.01 | -1.85% |
| ---- |
Data as of 4:00pm ET, 05/25/2022
Financials
| Next reporting date | August 16, 2022 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$10.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Waconia, Minnesota |
Forecasts
